Prevalence and outcomes of real-world bipolar depression patients underrepresented in guideline RCTs
Journal of Affective Disorders · 2026-12 · 414 · 122363
DOI: 10.1016/j.jad.2026.122363 ↗Kurz gefasst
Leitlinie in der Zeitschrift Journal of Affective Disorders, 2026-12. Verfasst von Michele Fornaro und 9 weiteren Autor:innen. Beteiligte Einrichtung: Section of Psychiatry Department of Neuroscience, Reproductive Sciences, and Dentistry, University School of Medicine Federico II, Naples, Italy. Ele…. Hauptthemen laut MEDLINE: Bipolar Disorder, Randomized Controlled Trials as Topic. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 45 Literaturangaben.
Themen: Depression
Abstract (Originalsprache)
BACKGROUND: The present study aimed to address the gap between treatment guidelines and real-world management of acute bipolar depression by examining the prevalence, clinical features, and patient-perceived improvement after pharmacotherapy among bipolar outpatients who would be ineligible for an average randomized controlled trial (RCT). METHODS: This cross-sectional study classified bipolar depressed outpatients as RCT-eligible or RCT-ineligible using the Trial Eligibility Index (TEI), while retaining the TEI as the primary continuous measure of RCT representativeness. Patient-perceived improvement after pharmacotherapy was assessed during routine clinical evaluation. Descriptive analyses were followed by multivariable regression and exploratory random-forest variable-importance analyses. RESULTS: At the prespecified TEI cutoff of 75, 53/122 patients (43.4%) were RCT-eligible. RCT-eligible patients had greater odds of reporting perceived improvement than RCT-ineligible patients (OR = 9.83, 95%CI 4.17-23.18; p < 0.001). Sensitivity analyses produced the same classification at a cutoff of 70 and preserved the direction of association at a cutoff of 80 (OR = 9.33, 95%CI 1.14-76.09; p = 0.013). The continuous TEI was associated with several psychiatric and medical characteristics in multivariable analysis. CONCLUSIONS: Targeted RCTs, broader eligibility criteria, subgroup analyses, and observational cohorts are needed to improve the evidence base for underrepresented patients with bipolar depression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Section of Psychiatry Department of Neuroscience, Reproductive Sciences, and Dentistry, University School of Medicine Federico II, Naples, Italy. Electronic address: dott.fornaro@gmail.com.
- Federico II University of Naples, Italy.
- Section of Psychiatry Department of Neuroscience, Reproductive Sciences, and Dentistry, University School of Medicine Federico II, Naples, Italy.
- Section of Psychiatry Department of Neuroscience, Reproductive Sciences, and Dentistry, University School of Medicine Federico II, Naples, Italy; Section of Psychiatry, Laboratory of Translational and Molecular Psychiat…
Zitieren
APA
Fornaro, M., Di Lorenzo, C., Sarto, V., Zeoli, E. L., Pascucci, E., Ferraioli, G., Passeretti, A., Pariano, R., Iasevoli, F., & de Bartolomeis, A. (2026). Prevalence and outcomes of real-world bipolar depression patients underrepresented in guideline RCTs. Journal of Affective Disorders, 414, 122363. https://doi.org/10.1016/j.jad.2026.122363
Vancouver
Fornaro M, Di Lorenzo C, Sarto V, Zeoli EL, Pascucci E, Ferraioli G, et al. Prevalence and outcomes of real-world bipolar depression patients underrepresented in guideline RCTs. Journal of Affective Disorders. 2026;414:122363. doi:10.1016/j.jad.2026.122363
BibTeX
@article{Fornaro2026,
author = {Fornaro, Michele and Di Lorenzo, Chiara and Sarto, Valeria and Zeoli, Erica Luce and Pascucci, Elena and Ferraioli, Gennaro and Passeretti, Alessandro and Pariano, Riccardo and Iasevoli, Felice and de Bartolomeis, Andrea},
title = {Prevalence and outcomes of real-world bipolar depression patients underrepresented in guideline RCTs},
journal = {Journal of Affective Disorders},
year = {2026},
volume = {414},
pages = {122363},
doi = {10.1016/j.jad.2026.122363}
}
EUVIMED